Login
Velsera blog - insights on the future of precision medicine
BLOG

Discussing the future of precision medicine.

A Story of Support: Our Innovation Improves Your Results

Whether you’re a clinician or a researcher, you’ve likely been in a situation where you’re waiting on a report. You’re excited about what you might learn, how you might forward your mission, which could be working on patient care directly or taking b...
go to article

STAARpipeline apps: Enhancing Rare Variant Analysis in Whole-Genome Sequencing Studies

Overview of STAARpipeline apps
go to article

Level Up your Documentation Processes and Systems to Comply with FDA Final Rule Stages 1 & 2

FDA’s ruling on enforcement of in vitro diagnostic (IVD) medical device requirements for laboratory-...
go to article

Enhancing the Precision Medicine Journey

Five Focus Areas for Our Chief Customer Officer
go to article

Get Ready to Comply with FDA Final Rule Stages 1 & 2: Yeah, We Mean You

FDA's New LDT Rule: An Overview
go to article

Navigating your molecular lab’s test selection and development over the next two years

With the FDA’s publication of the final rule on laboratory developed tests (LDTs) on May 6, 2024, cl...
go to article

Unravelling Cellular Complexity: Exploring 3D Genome Structure and DNA Methylation with the snM3C Pipeline

Understanding the three-dimensional genome architecture is an important feature when analysing gene ...
go to article

Four Years, Five Stages: the FDA's Final Rule on LDTs

After over a decade-long saga, the Food and Drug Administration (FDA) published its final rule on La...
go to article

Making the Most of Multi-Modal Tissue Atlases with Cloud Compute

Why Tissue Atlases? The omics revolution has fundamentally altered our understanding of cellular het...
go to article

Meeting the NIH Data Management and Sharing (DMS) policy requirements

The Velsera suite of NIH-funded platforms including Cancer Genomics Cloud (CGC), BioData Catalyst Po...
go to article